EU OMBUDSMAN SAYS EMA MUST RELEASE TEST ADVERSE REACTION REPORTS
May 1st, 2010
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMA) has come under pressure from the European Ombudsman to release information held on adverse reactions to drugs in trials. The official, Nikiforos Diamandouros, has said EU rules on releasing information associated with its decision-making "apply to all documents held by EMA". He noted: "EMA plays a crucial role in the approval and monitoring of medicines placed on the market. Since its work has a direct impact on the health of European citizens, it is of utmost importance for EMA to give the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.